| Cardiomyopathy |
1 |
1 |
| Hypertension |
0 |
0.93 |
| Heart |
0 |
0.6 |
| Heart Failure (HF) |
0 |
0.57 |
| Angiotensin II Receptor Blockade |
0 |
0.43 |
| Takotsubo Cardiomyopathy |
0 |
0.32 |
| ACE Inhibitor |
0 |
0.3 |
| Receptors |
0 |
0.3 |
| Stress |
0 |
0.3 |
| Myocardial Infarction (MI) |
0 |
0.27 |
| Healthcare and Medical Technology |
0 |
0.16 |
| Lipids Management |
0 |
0.16 |
| Medical Life |
0 |
0.16 |
| Antiplatelet Agent |
0 |
0.15 |
| Beta-Adrenergic Agonist |
0 |
0.15 |
| Clinical Research |
0 |
0.15 |
| Diuretics |
0 |
0.15 |
| Fellowship |
0 |
0.15 |
| Hospital |
0 |
0.15 |
| Infarction |
0 |
0.15 |
| Match |
0 |
0.15 |
| NHS |
0 |
0.15 |
| Psychotropic Drugs |
0 |
0.15 |
| Statins |
0 |
0.15 |